SIBO Breath Test vs. Stool Testing: What's the Difference?

Bloating. Gas. Abdominal discomfort. Diarrhea. Constipation. Food intolerance.

These symptoms can all raise questions about small intestinal bacterial overgrowth, or SIBO.

And when patients start looking for answers, two tests often enter the conversation:

A SIBO breath test and a stool microbiome test

They are sometimes treated as interchangeable.

They're not.

A breath test and a stool test measure very different aspects of gastrointestinal biology, and understanding that distinction can help clinicians choose the right tool for the right clinical question.

The simplest way to think about it is:

A SIBO breath test asks: "Is abnormal microbial fermentation occurring where and when we wouldn't expect it?"

A stool microbiome test asks:

"What does the bacterial ecosystem look like?"

Both can provide useful information.

But they are not diagnosing the same thing.

What Is SIBO?

SIBO refers to an abnormal increase or alteration of microorganisms within the small intestine.

The small intestine is not sterile, but it normally contains a much lower microbial biomass than the colon.

When microbial populations or fermentation activity increase abnormally in the small intestine, symptoms can include:

• bloating
• abdominal distension
• excessive gas
• abdominal pain
• diarrhea
• constipation
• nausea
• food intolerance

Importantly, these symptoms are not specific to SIBO. They can also occur in IBS, carbohydrate malabsorption, motility disorders and other gastrointestinal conditions.

That is one reason testing is often used alongside the clinical history rather than diagnosing SIBO from symptoms alone.

What Does a SIBO Breath Test Measure?

SIBO breath testing does not directly measure bacteria.

Instead, it measures gases produced when microorganisms ferment a carbohydrate substrate.

Typically, a patient drinks either:

• glucose, or
• lactulose

Breath samples are then collected over time and analyzed for gases produced through microbial metabolism.

The most commonly measured gases are:

• Hydrogen
• Methane
• Some newer testing platforms also measure:
• Hydrogen sulfide

Humans do not produce meaningful amounts of hydrogen or methane through their own metabolism. These gases are generated primarily by microorganisms.

Once produced in the intestine, the gases can enter the bloodstream, travel to the lungs and eventually be detected in exhaled breath.

So rather than asking which bacteria are present, breath testing is looking for a pattern of microbial fermentation over time.

The 2017 North American Consensus considers a rise in hydrogen of at least 20 ppm above baseline within 90 minutes during glucose or lactulose testing consistent with SIBO. Methane levels of 10 ppm or greater at any point are considered methane-positive.

Hydrogen SIBO and Methane Overgrowth Are Not Exactly the Same Thing

This distinction has become increasingly important.

Hydrogen elevation is generally discussed in the context of SIBO.

Methane is somewhat different because methane is produced by archaea, not bacteria.

For that reason, elevated methane is increasingly referred to as:

Intestinal Methanogen Overgrowth, or IMO

rather than methane-predominant SIBO.

IMO is particularly associated with constipation and slowed intestinal transit.

A 2026 consensus guideline continues to recommend simultaneous measurement of hydrogen and methane when evaluating suspected SIBO and IMO, while emphasizing standardized preparation and cautious interpretation of results.

What About Hydrogen Sulfide?

Hydrogen sulfide is another gas produced through microbial metabolism.

It has attracted particular attention because higher levels may be associated with diarrheal symptoms in some individuals.

A 2026 real-world study of 6,000 patients undergoing three-gas breath testing examined hydrogen, methane and hydrogen sulfide together and found distinct relationships between gas patterns and gastrointestinal symptoms.

This is another example of what breath testing does particularly well:

It gives us information about microbial fermentation activity.

But it still doesn't tell us the complete composition of the microbial ecosystem producing those gases.

What Does Stool Testing Measure?

A stool microbiome test approaches the gut from a completely different direction.

Instead of measuring gases, it analyzes microorganisms—or their DNA—present in a stool sample.

Depending on the technology used, stool testing can provide information about:

• bacterial species
• relative abundance
• microbial diversity
• community structure
• dominance patterns
• potentially disruptive organisms
• inferred microbial functional capacity

The important distinction is anatomical.

Stool primarily reflects the distal intestinal ecosystem.

By the time material becomes stool, it has moved through the small intestine and colon and contains large amounts of microorganisms originating from the colonic microbial community.

That means stool testing is excellent for studying the bacterial ecosystem represented in feces.

It is not a validated direct diagnostic test for SIBO.

Can a Stool Test Tell You If Someone Has SIBO?

Not reliably.

This is one of the biggest misconceptions in microbiome testing.

A stool sample cannot tell us with certainty where within the gastrointestinal tract a bacterium was living.

Imagine that a stool test identifies a high level of a particular organism.

That does not tell us whether that organism was:

• primarily living in the colon
• transiently passing through
• elevated in the small intestine
• or present throughout multiple regions of the gut

Location matters in SIBO.

SIBO is fundamentally about microbial overgrowth or abnormal microbial activity in the small intestine.

Stool is collected at the other end of the gastrointestinal tract.

So while a stool microbiome test can provide useful ecological context, it should not be interpreted as:

"This bacteria is elevated in stool, therefore this patient has SIBO."

That conclusion goes beyond what the test measures.

So Why Can Stool Testing Still Be Helpful in Someone With SIBO?

Because SIBO doesn't exist in isolation from the rest of the gastrointestinal ecosystem.

A patient may have evidence of abnormal small intestinal fermentation and a disrupted colonic microbial ecosystem.

Those are related questions, but they aren't identical.

A stool microbiome test may help a clinician understand:

• overall microbial diversity
• dominance patterns
• relative abundance of major bacterial groups
• expansion of potentially disruptive organisms
• depletion of important commensals
• ecosystem resilience
• potential functional patterns such as fermentation or short-chain fatty acid production

That information may help explain why symptoms persist, why someone repeatedly develops SIBO or how the larger microbial environment might be supported alongside treatment.

It gives the clinician ecosystem context.

Breath Testing Has Limitations Too

Breath testing is useful, but it is not a perfect test.

Several factors can influence results, including:

• preparation before testing
• choice of glucose vs. lactulose
• intestinal transit time
• recent antibiotics or laxatives
• diet in the days before testing
• interpretation criteria

A 2023 review of hydrogen-methane breath testing emphasized that physiological and technical factors can meaningfully affect test performance and interpretation.

For example, rapid intestinal transit can complicate lactulose testing because the substrate may reach the colon sooner than expected, potentially creating fermentation that could be mistaken for small intestinal activity.

Different testing protocols can also produce different rates of positive results. One study comparing breath-testing protocols found that changing substrate dose and diagnostic criteria substantially altered the percentage of patients classified as positive.

That doesn't make breath testing useless.

It means it should be interpreted alongside the patient's symptoms, history, risk factors and physiology.

What Is the Gold Standard for SIBO?

Historically, small-bowel aspirate and culture has been considered a reference standard for diagnosing SIBO.

During an endoscopic procedure, fluid from the small intestine is collected and cultured to measure bacterial concentration.

But this approach has major limitations.

It is invasive, expensive, technically difficult, susceptible to contamination, and samples only a small region of a very long organ.

For those reasons, breath testing remains the most widely used noninvasive approach in clinical practice.

There is currently no perfect test for SIBO.

What If a Breath Test Is Positive but the Stool Microbiome Looks Healthy?

That can happen.

And it isn't necessarily contradictory.

Remember:

The tests are examining different compartments and different biological questions.

A person might have abnormal fermentation occurring in the small intestine while maintaining relatively good microbial diversity in the colon.

Conversely, someone could have significant disruption of their fecal microbial ecosystem but a negative SIBO breath test.

One does not necessarily predict the other.

What If the Breath Test Is Negative but Symptoms Continue?

This is where broadening the clinical investigation can become important.

Bloating, gas, diarrhea and constipation have many potential contributors beyond SIBO.

Depending on the individual, clinicians may consider:

• carbohydrate malabsorption
• altered motility
• constipation
• bile acid abnormalities
• pancreatic or digestive function
• food intolerances
• disorders of gut-brain interaction
• inflammatory conditions
• medication effects
• broader microbial ecosystem disruption

A negative SIBO test doesn't mean:

"Nothing is wrong with the gut."

It simply means the test did not demonstrate the specific gas pattern used to identify SIBO or IMO under those testing conditions.

Where GutID Fits

GutID is not designed to replace a SIBO breath test.

The two tests answer different questions.

If the clinical question is:

"Does this patient have evidence of abnormal hydrogen or methane production consistent with SIBO or IMO?"

A breath test is the more appropriate tool.

If the question is:

"What does this patient's bacterial ecosystem look like?"

That is where comprehensive stool microbiome testing adds information.

Using Titan-1™ long-read ribosomal sequencing, GutID is designed to characterize the bacterial community at high taxonomic resolution and evaluate that information within the context of the larger ecosystem.

For a clinician working with a patient who has recurrent bloating or SIBO, that can create a broader set of questions:

What organisms dominate the ecosystem?

What does diversity and evenness look like?

Are key commensal populations represented?

Are there potential ecosystem disruptors?

What does the community look like after antibiotics or antimicrobial treatment?

And perhaps most importantly:

What conditions might be allowing the problem to keep coming back?

SIBO Is a Location Question. Stool Testing Is an Ecosystem Question.

That is ultimately the most important distinction.

SIBO breath testing helps evaluate where abnormal microbial fermentation may be occurring.

Stool microbiome testing helps characterize which microorganisms make up the distal gut ecosystem and how that community is structured.

Neither test answers every question.

And neither should be forced to answer a question it wasn't designed to answer.

Instead of asking:

"Which test is better?"

A more useful question is:

"What are we trying to understand?"

If you are investigating suspected small intestinal bacterial overgrowth, breath testing may provide important functional information about hydrogen and methane production.

If you want to understand the larger bacterial ecosystem, stool microbiome testing provides a different layer of information.

And in some patients, using both perspectives may help clinicians see a more complete picture.

References

• Rezaie A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017;112(5):775–784.
• Perets TT, et al. A national consensus guideline on the performance and interpretation of hydrogen- and methane-based breath tests for carbohydrate malabsorption, small intestinal bacterial overgrowth, and intestinal methanogen overgrowth. Ann Gastroenterol. 2026;39(4):383–389.
• Tansel A, Levinthal DJ. Understanding Our Tests: Hydrogen-Methane Breath Testing to Diagnose Small Intestinal Bacterial Overgrowth. Clin Transl Gastroenterol. 2023;14(4):e00567.
• Pimentel M, et al. Real-world Study of Three-gas Breath Testing Nationwide and the Association With Symptoms. J Clin Gastroenterol. 2026.